To The Moon

Goldman Sachs analyst Mark Delaney is cautious on the US Autos sector ahead of the Q1 earnings season. The analyst ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Sono Group, $Arrival(ARVL)$, Rivian, Tesla, Faraday Future, Xpeng and Lucid slid between 1% and 5%.

AMC, $GameStop(GME)$, Bed Bath & Beyond, $Koss(KOSS)$, $Workhorse(WKHS)$ and WISH fell between 1% and 6%.

Olivier Le Moal/iStock via Getty Images Dividend increases are the name of the game. 2022 is shaping up much like 2021. Dividend growth stocks continue to announce strong dividend increases and help us grow our dividend income. The bottom line is this. We love dividend increases and are always watching the newswire for dividend increase announcements. Therefore, typically, each month, we write an article summarizing the dividend increases that are expected during the month. Today's article featu

coward_lion/iStock via Getty Images Summary NIO Inc (NYSE:NIO) presented full-year earnings on Thursday the 24th after market close, which prompted a sell-off in post-market trading which extended int

This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AMC Entertainment Holdings Inc. Cl A slipped 9.01% to $21.21 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 2.26% to 14,204.17 and Dow Jones Industrial Average falling 0.80% to 34,641.18. AMC Entertainment Holdings Inc. Cl A closed $51.41 below its 52-week high , which the company achieved on June 2nd.Trading

ValleraTo/iStock via Getty Images After sharp gains last week, the clinical-stage biotech, Longeveron closed lower for the second straight session on Tuesday after the company announced the appointment of Chris Min as its Chief Medical Officer . Longeveron shares recorded the third-best weekly gain last week on the back of peer-reviewed data on its Alzheimer’s disease candidate Lomecel-B. In an announcement Tuesday, the company said that its global R&D efforts would be led by Dr. Min effec

The California company has made plenty of shareholders wealthy. Could you be next?

Given a war and inflation have marked the start of 2022, investors would be forgiven for holding their breath over the rest of the year's offerings.Our call of the day from a team at Saxo Bank sees a "wild ride" ahead for the second quarter, and offers advice on which companies will best survive the upheaval.The world is living through nothing less than "the arrival of the endgame for the paradigm that has shaped markets since the advent of the Greenspan Federal Reserve put in the wake of the LT